{"id":2650412,"date":"2026-08-27T09:54:58","date_gmt":"2026-08-27T13:54:58","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-approves-landmark-cancer-drug-that-extended-patients-lives-in-trial\/"},"modified":"2026-08-27T10:03:08","modified_gmt":"2026-08-27T14:03:08","slug":"fda-approves-landmark-cancer-drug-that-extended-patients-lives-in-trial","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-approves-landmark-cancer-drug-that-extended-patients-lives-in-trial\/","title":{"rendered":"FDA Approves &#8216;Landmark&#8217; Cancer Drug That Extended Patients&#8217; Lives in Trial"},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">22<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Ffda-approves-landmark-cancer-drug-that-extended-patients-lives-in-trial%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2650412&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><p>The article reports that the U.S. Food and Drug Administration (FDA) has approved a new drug called Rasonque for the treatment of advanced pancreatic cancer, a highly deadly form of cancer with historically limited treatment options. The drug nearly doubles patients\u2019 median survival time, from about 6.7 months with traditional chemotherapy to 13.2 months in <a href=\"https:\/\/amzn.to\/3YuVZYV\" >clinical trials involving 500 adults<\/a>. Rasonque targets the RAS protein, which promotes tumor growth. Researchers have called this growth a \u201clandmark\u201d breakthrough, and experts consider it possibly the most notable advance in pancreatic cancer treatment to date.The approval came ahead of schedule, reflecting the FDA\u2019s effort to accelerate promising therapies for serious conditions. Public attention increased after former Senator Ben Sasse, diagnosed with stage 4 pancreatic cancer, credited Rasonque with shrinking his tumors and extending his life. The drug\u2019s approval offers new hope for patients,given pancreatic cancer\u2019s <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/biden-budget-proposal-refers-to-mothers-as-birthing-people\/\" title=\"Biden Budget Proposal Refers To Mothers As \u2018Birthing People\u2019\">high mortality rate<\/a> and the challenge of late detection.  <\/p>\n<p class=\"readmore\">\n    <button onclick=\"showReadMore()\" id=\"readmorebtn\">Read more&#8230;<\/button>\n<\/p>\n<hr id=\"line\">\n<span id=\"more\"><br \/>\n<!DOCTYPE html PUBLIC \"-\/\/W3C\/\/DTD HTML 4.0 Transitional\/\/EN\" \"http:\/\/www.w3.org\/TR\/REC-html40\/loose.dtd\"><br \/>\n<?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><html><body><\/p>\n<section> \t\t\t\t<script>console.log(\"ad slot (AC1)\")<\/script><script>console.log(\"ad slot (IC1)\")<\/script><script>console.log(\"ad slot (IC2)\")<\/script><script>console.log(\"ad slot (IC3)\")<\/script><script>console.log(\"ad slot (IC4)\")<\/script><\/p>\n<p>The Food and Drug Administration announced Wednesday the approval of a new pancreatic cancer treatment drug that nearly doubles patients\u2019 survival times.<\/p>\n<p>Former GOP Sen. <a href=\"https:\/\/www.westernjournal.com\/facing-terminal-cancer-ben-sasse-hits-lifelong-politicians-truth-parent-best-job-title\/\" target=\"_blank\" rel=\"noopener\">Ben Sasse<\/a> of Nebraska has seen very positive results using it while it was still in its experimental phase.<\/p>\n<p>The drug, known as Rasonque, \u201ca tablet taken once daily, targets multiple forms of a protein called RAS, a key driver of tumor growth in most patients with pancreatic adenocarcinoma, which arises from cells lining the ducts of the pancreas,\u201d the FDA said in a <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-class-targeted-therapy-metastatic-pancreatic-cancer\" target=\"_blank\" rel=\"noopener\">news release<\/a>.<\/p>\n<p>Researchers have called it a \u201clandmark\u201d development, <a href=\"https:\/\/www.washingtonpost.com\/health\/2026\/08\/26\/fda-approves-landmark-pancreatic-cancer-drug-daraxonrasib\/\" target=\"_blank\" rel=\"noopener\">The Washington Post<\/a> reported.<\/p>\n<blockquote class=\"twitter-tweet\">\n<p dir=\"ltr\" lang=\"en\">The FDA approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer. <a href=\"https:\/\/t.co\/alJSgvEqtG\">https:\/\/t.co\/alJSgvEqtG<\/a> <a href=\"https:\/\/t.co\/KK7yf1KVR7\">pic.twitter.com\/KK7yf1KVR7<\/a><\/p>\n<p>\u2014 WFLA NEWS (@WFLA) <a href=\"https:\/\/x.com\/WFLA\/status\/2092717151794626885?\">August 26, 2026<\/a><\/p>\n<\/blockquote>\n<p><script async src=\"https:\/\/platform.x.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>Acting FDA Commissioner Kyle Diamantas said regarding the drug, \u201cToday\u2019s approval provides a critical new option for patients facing an extraordinarily difficult and historically hard-to-treat cancer. It is our fundamental duty to deliver more cures and meaningful treatments to patients as quickly as possible.\u201d<\/p>\n<p>\u201cI am immensely proud of the dedicated FDA scientists whose fast, thorough review and relentless commitment made this groundbreaking milestone a reality,\u201d he added.<\/p>\n<blockquote class=\"twitter-tweet\">\n<p dir=\"ltr\" lang=\"en\">Today we approved a first-in-class targeted therapy for metastatic pancreatic cancer \u2013 one of the hardest cancers to treat. Today\u2019s approval provides a critical new treatment for patients who\u2019ve had very few options. <a href=\"https:\/\/t.co\/6f9WWJUdQ3\">https:\/\/t.co\/6f9WWJUdQ3<\/a> <a href=\"https:\/\/t.co\/5PvYLk1ydr\">pic.twitter.com\/5PvYLk1ydr<\/a><\/p>\n<p>\u2014 FDA Drugs and Biologics (@FDADrugs) <a href=\"https:\/\/x.com\/FDADrugs\/status\/2092626146361811315?\">August 26, 2026<\/a><\/p>\n<\/blockquote>\n<p><script async src=\"https:\/\/platform.x.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>The <a href=\"https:\/\/www.westernjournal.com\/newly-released-covid--shows-fda-head-warning-fauci-vax-side-effects-eerie-4-word-response-disgraced-covid-chief\/\" target=\"_blank\" rel=\"noopener\">FDA<\/a> noted, \u201cApproximately 90% to 95% of the 67,000 new cases of pancreatic cancer diagnosed in the United States each year are pancreatic adenocarcinoma, according to the National Cancer Institute. Despite representing roughly 3.2% of all cancer diagnoses, pancreatic adenocarcinoma accounts for a disproportionately high  of cancer deaths, owing to its typically late detection, aggressive disease course, and historically limited treatment options.\u201d<\/p>\n<p>The average survival time for those diagnosed with pancreatic adenocarcinoma is 6.7 months for those receiving traditional chemotherapy.<\/p>\n<p>However, patients who took Rasonque had a median survival period of 13.2 months in a trial with 500 adults.<\/p>\n<p>Dr. Angelo de Claro, director of the FDA\u2019s Oncology Center of Excellence, said, \u201cThis drug showed unprecedented results in an area of high unmet need.\u201d<\/p>\n<p>\u201cThe approval was granted 6.5 months before the user fee deadline, demonstrating the FDA\u2019s commitment to accelerating the approval of new cancer treatments for patients with serious and life-threatening conditions,\u201d he added.<\/p>\n<p>The FDA issued a <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-permits-expanded-access-investigational-pancreatic-cancer-drug\" target=\"_blank\" rel=\"noopener\">\u201csafe to proceed\u201d letter<\/a> in April, allowing patients expanded access to the experimental drug.<\/p>\n<p>The Associated Press <a href=\"https:\/\/www.wfla.com\/news\/national\/fda-approves-landmark-pancreatic-cancer-drug-thats-shown-to-improve-survival\/\" target=\"_blank\" rel=\"noopener\">reported,<\/a> \u201cThe drug garnered public attention earlier this year when former Sen. Ben Sasse, R-Neb., described on CBS\u2019 \u201960 Minutes\u2019 how he has had less pain while taking it. A surge in public interest led the FDA to allow \u2018expanded access,\u2019 before the drug\u2019s official approval, for patients who met certain criteria.\u201d<\/p>\n<blockquote class=\"twitter-tweet\">\n<p dir=\"ltr\" lang=\"en\">Former Sen. Ben Sasse, given 3-4 months to live with Stage 4 pancreatic cancer, credits the experimental RAS inhibitor daraxonrasib (FDA-approved today as Rasonque) for shrinking tumors over 76% and extending his life. Trial nearly doubled survival.<a href=\"https:\/\/t.co\/bsZemv41sR\">https:\/\/t.co\/bsZemv41sR<\/a><\/p>\n<p>\u2014 Aftab Khan, MD (@aftab_usa) <a href=\"https:\/\/x.com\/aftab_usa\/status\/2092694399943676071?\">August 26, 2026<\/a><\/p>\n<\/blockquote>\n<p><script async src=\"https:\/\/platform.x.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<p>Harsh Singh, the program director of hepatobiliary and pancreas oncology at Mass General Brigham Cancer Institute, told <a href=\"https:\/\/www.washingtonpost.com\/health\/2026\/05\/31\/hotly-anticipated-pancreatic-cancer-drug-results-open-new-era-lethal-cancer\/\" target=\"_blank\" rel=\"noopener\">The Washington Post<\/a>, \u201cThis is possibly the biggest advance we have seen in pancreatic cancer, period.\u201d<\/p>\n<div style=\"background-color: #f7f7f7; color: #171717; display: flex;font-size: 16px;font-weight: 600;line-height: 1.5;margin: 24px 0;padding: 18px 20px 18px 30px;text-align: left;\">\n<div style=\"align-self: stretch;border-left: 3px solid #171717;flex-shrink: 0;padding-left: 20px;\"><\/div>\n<p><a style=\"text-decoration: none;\" href=\"https:\/\/www.google.com\/preferences\/source?q=https:\/\/www.westernjournal.com\/\">Choose The Western Journal as your preferred source on Google and never miss reporting that defends truth, protects freedom, and advances Western civilization<\/a><\/div>\n<p style=\"border: 1px solid #f5f5f5; padding: 16px;\">Advertise with The Western Journal and reach millions of highly engaged readers, while supporting our work. <a href=\"https:\/\/www.westernjournal.com\/advertise-us\/?wj_source=article\">Advertise Today<\/a>.<\/p>\n<div style=\"position: relative;\">\n<div class=\"ff-fancy-header-container\"> \t\t\t \t<\/div>\n<div class=\"entry-submit-correction inner-content\">\n<div class=\"correction-form\">\n<form style=\"display: none;\">\n<div class=\"sc-name-field\"> \t\t\t\t\t\t<label>* Name<\/label> \t\t\t\t\t\t<br \/> \t\t\t\t\t\t<input type=\"text\" name=\"name\" required> \t\t\t\t\t<\/div>\n<div class=\"sc--field\"> \t\t\t\t\t\t<label>* <\/label> \t\t\t\t\t\t<br \/> \t\t\t\t\t\t<input type=\"text\" name=\"\" required> \t\t\t\t\t<\/div>\n<p> \t\t\t\t\t<label>* Message<\/label> \t\t\t\t\t<br \/> \t\t\t\t\t<textarea name=\"message\" required><\/textarea> \t\t\t\t\t \t\t\t\t\t<\/p>\n<div class=\"required-message\" style=\"display: none; padding-bottom: 15px;\">* All fields are required.<\/div>\n<p> \t\t\t\t\t<input type=\"submit\" value=\"Submit\" onclick=\"event.preventDefault(); firefly_sc();\"> \t\t\t\t\t \t\t\t\t\t<\/p>\n<div class=\"firefly-sc-confirm\" style=\"display: none;\">Success!<\/div>\n<\/p><\/form>\n<\/p><\/div>\n<\/p><\/div>\n<p> \t\t<script> \t\t\tfunction firefly_sc() { \t\t\t\tif( typeof window.captchaPublicKey == typeof undefined ){ \t\t\t\t\tconsole.error('window.captchaPublicKey is not defined'); \t\t\t\t} \t\t\t\tgrecaptcha.execute( window.captchaPublicKey, { action: 'submit_correction' } ).then( function( token ) { \t\t\t\t\tvar opts = { \t\t\t\t\t\taction:    'firefly_sc_submit', \t\t\t\t\t\tname:      document.querySelector( '.entry-submit-correction [name=\"name\"]' ).value, \t\t\t\t\t\t:     document.querySelector( '.entry-submit-correction [name=\"\"]' ).value, \t\t\t\t\t\tmessage:   document.querySelector( '.entry-submit-correction [name=\"message\"]' ).value, \t\t\t\t\t\tpost_id:   firefly_post_id, \t\t\t\t\t\tcap_token: token \t\t\t\t\t}  \t\t\t\t\tvar inputs = [ 'name', '', 'message' ];  \t\t\t\t\tfor( var i = 0; i < inputs.length; i++ ) if( ! ( opts[inputs[i]] = document.querySelector( '.entry-submit-correction [name=\"' + inputs[i] + '\"]' ).value ) ) { \t\t\t\t\t\tdocument.querySelector( '.entry-submit-correction .required-message' ).style.display = 'block'; \t\t\t\t\t\treturn; \t\t\t\t\t}  \t\t\t\t\tdocument.querySelector( '.entry-submit-correction input[type=\"submit\"]' ).style.display = 'none'; \t\t\t\t\tdocument.querySelector( '.entry-submit-correction .firefly-sc-submitting-img' ).src = firefly_loading_gif_url; \t\t\t\t\tdocument.querySelector( '.entry-submit-correction .firefly-sc-submitting-img' ).style.display = 'inline-block';  \t\t\t\t\tconsole.log( 'ma subbing' );  \t\t\t\t\tif( firefly_post_id ) opts['post_id'] = firefly_post_id;  \t\t\t\t\t\/* Send the data using post with element id name and name2*\/ \t\t\t\t\tvar posting = jQuery.post( firefly_ajax_url, opts );  \t\t\t\t\t\/* Alerts the results *\/ \t\t\t\t\tposting.done( function( response ) { \t\t\t\t\t\tif( response.success ) { \t\t\t\t\t\t\tconsole.log( response.data ); \t\t\t\t\t\t\tdocument.querySelector( '.entry-submit-correction .firefly-sc-submitting-img' ).style.display = 'none'; \t\t\t\t\t\t\tdocument.querySelector( '.entry-submit-correction .firefly-sc-confirm' ).style.display = 'block';  \t\t\t\t\t\t\tdataLayer.push( { 'event': 'submit-correction' } ); \t\t\t\t\t\t} \t\t\t\t\t}); \t\t\t\t}); \t\t\t} \t\t<\/script> \t     \t\t\t\t\t\t     \t\t\t\t\t<\/div>\n<p> \t\t\t\t\t \t\t\t<script>console.log(\"ad slot (BA1)\")<\/script> \t\t<\/p>\n<div class=\"ff-fancy-header-container\"> \t\t\t \t<\/div>\n<\/section>\n<p><\/body><\/html><\/p>\n<p><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FDA approves groundbreaking pancreatic cancer drug, doubling survival times. Former Sen. Sasse reports positive results during trials<\/p>\n","protected":false},"author":1,"featured_media":2650413,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/www.westernjournal.com\/wp-content\/uploads\/2026\/08\/FDA-approval-cancer-drug.jpg","fifu_image_alt":"","footnotes":""},"categories":[33651],"tags":[51067,84375,64563,65128,84750],"class_list":["post-2650412","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-the-western-journal","tag-cancer-drug","tag-clinical-trial","tag-fda-approval","tag-medical-breakthrough","tag-oncology-treatment"],"fifu_image_url":"https:\/\/www.westernjournal.com\/wp-content\/uploads\/2026\/08\/FDA-approval-cancer-drug.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2650412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2650412"}],"version-history":[{"count":3,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2650412\/revisions"}],"predecessor-version":[{"id":2650421,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2650412\/revisions\/2650421"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2650413"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2650412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2650412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2650412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}